World's Best Scientists 2026 revealed!
Adelheid Cerwenka

Adelheid Cerwenka

D-Index & Metrics

Immunology

D-Index
65
Citations
16708
World Ranking
2828
National Ranking
187

Adelheid Cerwenka publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Adelheid Cerwenka sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 171 publications — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Adelheid Cerwenka D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Adelheid Cerwenka sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 65 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Adelheid Cerwenka is affiliated with Heidelberg University in Germany and has a significant research presence in the fields of immunology and microbiology, with substantial contributions to medicine. Their research output includes 68 publications focusing on immunology and microbiology and 32 on medicine.

The scientist's work spans several subfields such as immunology, oncology, molecular biology, hepatology, and epidemiology. Their main research themes center on immune cell function and interaction, immune cells in cancer, T-cell and B-cell immunology, CAR-T cell therapy research, IL-33, ST2, and ILC pathways, immunotherapy and immune responses, and immune response and inflammation.

Recent publications by Cerwenka include:

  • "Single-Cell RNA Sequencing of Tumor-Infiltrating NK Cells Reveals that Inhibition of Transcription Factor HIF-1α Unleashes NK Cell Activity," 2020, Immunity
  • "Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8," 2022, Science Advances
  • "Type 1 Treg cells promote the generation of CD8+ tissue-resident memory T cells," 2020, Nature Immunology
  • "Targeting of Scavenger Receptors Stabilin-1 and Stabilin-2 Ameliorates Atherosclerosis by a Plasma Proteome Switch Mediating Monocyte/Macrophage Suppression," 2022, Circulation
  • "TGF-β2 silencing to target biliary-derived liver diseases," 2020, Gut

Cerwenka's frequent coauthors include Ana Stojanovic, Carolina De La Torre, Michael Platten, Tomáš Hofman, and Carsten Sticht. Their collaborative relationships have contributed to a diverse range of publications.

The scientist's work has been published frequently in venues such as bioRxiv (Cold Spring Harbor Laboratory), Journal for ImmunoTherapy of Cancer, OncoImmunology, Frontiers in Immunology, and the European Journal of Immunology.

Best Publications

  • Natural killer cells, viruses and cancer.

    Adelheid Cerwenka;Lewis L. Lanier

  • Retinoic Acid Early Inducible Genes Define a Ligand Family for the Activating NKG2D Receptor in Mice

    Adelheid Cerwenka;Alexander B.H Bakker;Terri McClanahan;Janet Wagner

  • Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo

    Adelheid Cerwenka;Jody L. Baron;Lewis L. Lanier

  • Natural killer cell memory in infection, inflammation and cancer

    Adelheid Cerwenka;Lewis L. Lanier

  • NKG2D ligands in tumor immunity

    N Nausch;A Cerwenka

  • Tumor-Infiltrating Monocytic Myeloid-Derived Suppressor Cells Mediate CCR5-Dependent Recruitment of Regulatory T Cells Favoring Tumor Growth

    Eva Schlecker;Ana Stojanovic;Christian Eisen;Christian Quack

  • Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors.

    Jing Ni;Matthias Miller;Ana Stojanovic;Natalio Garbi;Natalio Garbi

  • Natural Killer Cell Accumulation in Tumors Is Dependent on IFN-γ and CXCR3 Ligands

    Marco Wendel;Ioanna E. Galani;Elisabeth Suri-Payer;Adelheid Cerwenka

  • Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke.

    Arthur Liesz;Wei Zhou;Éva Mracskó;Simone Karcher

  • DAP12-Deficient Mice Fail to Develop Autoimmunity Due to Impaired Antigen Priming

    Alexander B.H. Bakker;Robert M. Hoek;Adelheid Cerwenka;Bianca Blom

  • Ligands for natural killer cell receptors: redundancy or specificity.

    Adelheid Cerwenka;Lewis L. Lanier

  • Single-Cell RNA Sequencing of Tumor-Infiltrating NK Cells Reveals that Inhibition of Transcription Factor HIF-1α Unleashes NK Cell Activity.

    Jing Ni;Jing Ni;Xi Wang;Ana Stojanovic;Ana Stojanovic;Qin Zhang

  • Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2

    Sonja Textor;Nathalie Fiegler;Annette Arnold;Angel Porgador

  • Migration Kinetics and Final Destination of Type 1 and Type 2 CD8 Effector Cells Predict Protection against Pulmonary Virus Infection

    Adelheid Cerwenka;Tammy M. Morgan;Allen G. Harmsen;Richard W. Dutton

  • Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease

    Francesca Vinchi;Francesca Vinchi;Francesca Vinchi;Milene Costa da Silva;Giada Ingoglia;Sara Petrillo

  • Radiation effects on antitumor immune responses: current perspectives and challenges.

    Thomas Walle;Rafael Martinez Monge;Adelheid Cerwenka;Daniel Ajona

  • The TREM-1/DAP12 pathway.

    Anja S. Tessarz;Adelheid Cerwenka

  • Tricking the balance: NK cells in anti-cancer immunity

    Jens Pahl;Adelheid Cerwenka

  • In vivo persistence of CD8 polarized T cell subsets producing type 1 or type 2 cytokines

    Adelheid Cerwenka;Laura L. Carter;Joyce B. Reome;Susan L. Swain

  • Proliferating Cell Nuclear Antigen Is a Novel Inhibitory Ligand for the Natural Cytotoxicity Receptor NKp44

    Benyamin Rosental;Michael Brusilovsky;Uzi Hadad;Dafna Oz

  • Naive, effector, and memory CD8 T cells in protection against pulmonary influenza virus infection: Homing properties rather than initial frequencies are crucial

    Adelheid Cerwenka;Tammy M. Morgan;Richard W. Dutton

Frequent Co-Authors

Carsten Watzl
Carsten Watzl TU Dortmund University
Lewis L. Lanier
Lewis L. Lanier University of California, San Francisco
Angel Porgador
Angel Porgador Ben-Gurion University of the Negev
Martina U. Muckenthaler
Martina U. Muckenthaler Heidelberg University
Richard W. Dutton
Richard W. Dutton University of Massachusetts Chan Medical School
Gerhard Moldenhauer
Gerhard Moldenhauer German Cancer Research Center
Peter Schirmacher
Peter Schirmacher University Hospital Heidelberg
Alexander Steinle
Alexander Steinle Goethe University Frankfurt
Frank Momburg
Frank Momburg German Cancer Research Center
Antje Sucker
Antje Sucker University of Duisburg-Essen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to diverse healthcare careers, many of which can benefit from nursing qualifications. For those looking to pivot into nursing, several affordable and flexible online options exist. For instance, online adn programs for non nurses are designed specifically to help individuals with non-nursing backgrounds transition smoothly into the nursing profession.

Accelerated routes are also becoming increasingly popular among career changers. Programs such as the easiest accelerated nursing programs help expedite the process, enabling students to complete their Bachelor of Science in Nursing quickly and begin practicing sooner.

For those seeking quicker entry-level credentials, there are plenty of options. The easiest lpn programs to get into offer foundational nursing training and certification, often with flexible scheduling to accommodate working students.

Advancing further into specialized roles, the easiest np programs to get into provide pathways to become nurse practitioners, combining clinical practice with an advanced scope of care. These pathways complement immunology study by integrating clinical expertise with immunological knowledge.

Best Scientists Citing Adelheid Cerwenka

Trending Scientists

Recently Published Articles